Vertebral Compression Fracture

0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Amber Therapeutics
2 programs
VCFix Spinal System in stand-alone configurationN/A1 trial
VCFix Spinal System in stand-alone configurationN/A1 trial
Active Trials
NCT07301749RecruitingEst. Dec 2028
NCT07259811Active Not RecruitingEst. May 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
Amber TherapeuticsVCFix Spinal System in stand-alone configuration
Amber TherapeuticsVCFix Spinal System in stand-alone configuration

Clinical Trials (2)

NCT07301749Amber TherapeuticsVCFix Spinal System in stand-alone configuration

A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures.

Start: Nov 2025Est. completion: Dec 2028
N/ARecruiting
NCT07259811Amber TherapeuticsVCFix Spinal System in stand-alone configuration

Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration

Start: Sep 2023Est. completion: May 2026
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space